KEY WORDS: PTCA, restenosis, repeat PTCA, PTCA outcome determinants. (PTCA) Since its introduction' 12 ' successful percutaneous long-term success of PTCA. Reported restenosis transluminal coronary angioplasty (PTCA) has rates (14-47%) vary, depending in part on the denbeen shown to relieve angina and myocardial nition used, but according to the larger series' 18 " 22 ', ischaemia as assessed by exercise electrocardiogone patient in three with successful PTCA must raphy 13 ', thallium scintigraphy* 3 ' 4 ', and measureexpect recurrence, most of them within 6-8 months ment of coronary blood flow and myocardial after the intervention. Repeat PTCA has been metabolism' 5 ' 6 '. The original indications' 2 ' have been done with a higher primary success rate and fewer expanded' 7 " 171 . But regardless of selection criteria, complications than the initial procedure. Nevertherestenosis with recurrence of myocardial ischaemia less, there remains a substantial rate of second and symptoms remains the major problem limiting recurrences' 23 " 251 . The presence of angina as an indicator for restenosis has a predictive accuracy of only 56% Submitted for publication on 23 June 1986 and in revised form 21 after first and 67% after Second PTCA according tO OctobCTl986 the NHLBI report" 8231 . One patient in four with For the period that this work was carried out, Dr Rapold was restenosis has no chest pain. In a population at high supported by a grant oftheSwisi National Science Foundation.
Restenosis is the main problem limiting long-term success of percutaneous transluminal coronary angioplasty